How to calculate HbA1c levels is a question that matters for anyone managing diabetes or assessing their risk of developing it. HbA1c — glycated haemoglobin — reflects your average blood glucose over the preceding two to three months, making it one of the most clinically valuable markers in diabetes care. In the UK, results are reported in millimoles per mole (mmol/mol) using the IFCC standard, though older percentage values still appear in some contexts. This article explains how HbA1c is measured, what your result means, which factors can affect its accuracy, and how NHS guidance shapes diagnosis and treatment decisions.
Summary: HbA1c levels are calculated by measuring the percentage of haemoglobin that has become glycated, expressed in the UK as mmol/mol using the IFCC standard, with 48 mmol/mol or above diagnostic of type 2 diabetes.
- HbA1c reflects average blood glucose over the preceding two to three months, weighted towards the most recent four to six weeks.
- In the UK, results are reported in mmol/mol (IFCC); the conversion formula to NGSP percentage is: NGSP (%) = (0.09148 × IFCC mmol/mol) + 2.152.
- NHS thresholds: below 42 mmol/mol is normal; 42–47 mmol/mol indicates prediabetes; 48 mmol/mol or above is diagnostic of type 2 diabetes on a confirmed second sample.
- Conditions such as haemolytic anaemia, iron deficiency, haemoglobin variants, and advanced CKD can falsely lower or raise HbA1c, making alternative tests necessary.
- HbA1c must be measured on a venous sample in an accredited laboratory; point-of-care devices are not validated for diagnostic use.
- NICE NG28 recommends monitoring HbA1c every three to six months when treatment is being adjusted, and every six to twelve months once stable.
Table of Contents
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
What HbA1c Measures and Why It Matters
HbA1c measures the proportion of haemoglobin that has become glycated, providing a reliable two-to-three-month average of blood glucose; in the UK it is reported in mmol/mol using the IFCC standard.
HbA1c — formally known as glycated haemoglobin — is a blood marker that reflects average blood glucose levels over the preceding two to three months. When glucose circulates in the bloodstream, it binds irreversibly to haemoglobin, the protein found inside red blood cells. Because red blood cells have a lifespan of approximately 120 days, the proportion of haemoglobin that has become glycated provides a reliable window into longer-term glucose control, rather than a single snapshot in time. It is worth noting that HbA1c represents a weighted average, with glucose levels from the most recent four to six weeks contributing most to the result.
Unlike a fasting glucose test, which can fluctuate depending on recent meals or stress, HbA1c is considered a more stable and reproducible measure. This makes it particularly valuable for diagnosing type 2 diabetes, monitoring glycaemic control in people already living with diabetes, and identifying individuals at risk of developing the condition — a state sometimes referred to as prediabetes or non-diabetic hyperglycaemia (NDH).
In clinical practice, HbA1c is expressed in millimoles per mole (mmol/mol), following the International Federation of Clinical Chemistry (IFCC) standardisation adopted across the UK. You may occasionally encounter older percentage values based on the DCCT/NGSP scale, particularly in older literature or international sources. The two scales can be interconverted using the standard equation: NGSP (%) = (0.09148 × IFCC mmol/mol) + 2.152. For example, 48 mmol/mol corresponds to approximately 6.5%, and 53 mmol/mol to approximately 7.0%. NHS laboratories report exclusively in mmol/mol; validated online converters are available via the NGSP website if you need to cross-reference values.
Important: For diagnostic purposes, HbA1c must be measured on a venous blood sample analysed in an accredited, quality-assured laboratory using an IFCC-standardised method. Point-of-care devices and home testing kits are not validated for diagnosis and should not be used for this purpose. Understanding what this figure represents — and how it is derived — is the foundation for interpreting your result accurately.
Understanding Your HbA1c Result: NHS Reference Ranges
An HbA1c below 42 mmol/mol is normal, 42–47 mmol/mol indicates prediabetes, and 48 mmol/mol or above is diagnostic of type 2 diabetes when confirmed on a second sample.
The NHS and NICE use clearly defined thresholds to interpret HbA1c results, and knowing where your result sits within these ranges is essential for understanding its clinical significance.
Key reference ranges are as follows:
-
Below 42 mmol/mol: Normal — no evidence of diabetes or prediabetes
-
42–47 mmol/mol: Non-diabetic hyperglycaemia (prediabetes) — elevated risk of developing type 2 diabetes
-
48 mmol/mol or above: Diagnostic of type 2 diabetes (when confirmed on a second sample, unless symptoms are present)
When HbA1c should not be used for diagnosis
HbA1c is not appropriate as a diagnostic test in all circumstances. NICE guidance (NG28) advises that fasting plasma glucose or an oral glucose tolerance test (OGTT) should be used instead in the following situations:
-
Children and young people
-
Pregnancy (including suspected gestational diabetes)
-
Suspected type 1 diabetes or rapid-onset hyperglycaemia
-
Acute illness or recent use of medications that may cause rapid glycaemic change
-
Conditions affecting red blood cell lifespan or haemoglobin structure (see the section on accuracy below)
In an asymptomatic individual, a single raised HbA1c result is not sufficient to diagnose diabetes. NICE recommends that the test be repeated on a new sample to confirm the diagnosis. If the repeat result is discordant with symptoms, or if HbA1c is considered unreliable, fasting plasma glucose or OGTT should be used.
Treatment targets for people with diabetes
For people already diagnosed with diabetes, target HbA1c levels are individualised. NICE recommends a target of 48 mmol/mol for most people with type 2 diabetes managed with lifestyle measures or metformin alone, and 53 mmol/mol for those on medications that carry a risk of hypoglycaemia, such as sulphonylureas or insulin. Targets may be relaxed in older adults, those with frailty, or individuals where tight control poses a greater risk than benefit. Always discuss your personal target with your GP or diabetes care team, as individual circumstances matter considerably when interpreting these figures.
Factors That Can Affect HbA1c Accuracy
Conditions including haemolytic anaemia, iron deficiency, haemoglobin variants, and advanced CKD can falsely lower or raise HbA1c, prompting use of fructosamine or continuous glucose monitoring instead.
Whilst HbA1c is generally a robust and reliable test, several clinical conditions and physiological factors can interfere with its accuracy, leading to falsely elevated or falsely lowered results. Healthcare professionals are trained to recognise these situations and may request alternative tests — such as fructosamine or continuous glucose monitoring (CGM) — when HbA1c is deemed unreliable.
Conditions that may cause a falsely low HbA1c include:
-
Haemolytic anaemia (increased red blood cell turnover reduces glycation time)
-
Recent blood transfusion
-
Recent major blood loss
-
Erythropoietin (EPO) therapy
-
Splenomegaly
-
Haemoglobin variants such as sickle cell trait or haemoglobin C disease (effects are assay-dependent — your laboratory can advise on the most appropriate method)
-
Pregnancy (particularly the second and third trimesters)
-
Advanced chronic kidney disease (CKD): anaemia and reduced red blood cell lifespan in advanced CKD can lower HbA1c, making it unreliable; CGM, capillary glucose profiles, or fructosamine may be more appropriate in this context
Conditions that may cause a falsely high HbA1c include:
-
Iron deficiency anaemia (untreated iron deficiency may raise HbA1c; levels may fall after iron replacement without any true change in glycaemic control)
-
Vitamin B12 or folate deficiency
-
Splenectomy (prolonged red blood cell survival increases glycation time)
It is also worth noting that some research suggests people of Black African or Caribbean heritage, or South Asian heritage, may have slightly higher HbA1c readings at equivalent glucose concentrations. However, the evidence is not fully consistent, and NICE does not currently recommend ethnicity-specific diagnostic thresholds. If you have a known haemoglobin variant or a condition affecting red blood cell lifespan, inform your GP or practice nurse before testing, so that the most appropriate method of glucose assessment can be selected. Your laboratory can advise on which assay method is suitable for your circumstances.
| HbA1c Result | IFCC Value (mmol/mol) | NGSP/DCCT Value (%) | Clinical Interpretation | Recommended Action |
|---|---|---|---|---|
| Normal | Below 42 mmol/mol | Below ~6.0% | No evidence of diabetes or prediabetes | Routine review; maintain healthy lifestyle |
| Non-diabetic hyperglycaemia (prediabetes) | 42–47 mmol/mol | ~6.0–6.4% | Elevated risk of developing type 2 diabetes | Lifestyle advice; refer to NHS Diabetes Prevention Programme; repeat annually |
| Diagnostic of type 2 diabetes | 48 mmol/mol or above | ~6.5% or above | Confirms diabetes if repeated on second sample | Confirm with repeat test; initiate structured diabetes care plan |
| NICE treatment target (lifestyle/metformin) | 48 mmol/mol | ~6.5% | Recommended target for most adults with type 2 diabetes on low-risk regimens | Review diet, activity, and medication adherence if above target |
| NICE treatment target (hypoglycaemia risk) | 53 mmol/mol | ~7.0% | Target for those on sulphonylureas or insulin | Balance glycaemic control against hypoglycaemia risk; individualise target |
| IFCC–NGSP conversion formula | Any IFCC value | NGSP (%) = (0.09148 × IFCC) + 2.152 | Standard equation for converting between UK and older US/international units | NHS labs report in mmol/mol; use NGSP website converter to cross-reference |
| Monitoring frequency | Every 3–6 months | Every 6–12 months when stable | More frequent testing when treatment is being adjusted | Consult GP or diabetes team; adjust frequency based on clinical circumstances |
What Happens After an Abnormal HbA1c Reading
A prediabetes result triggers lifestyle advice and NHS Diabetes Prevention Programme referral, whilst a confirmed result of 48 mmol/mol or above initiates a structured diabetes care plan including education, medication review, and regular monitoring.
Receiving an abnormal HbA1c result can feel unsettling, but it is important to understand that it triggers a structured, supportive clinical pathway rather than an immediate diagnosis in isolation. The steps that follow will depend on whether the result falls in the prediabetes range or meets the threshold for a diabetes diagnosis.
Urgent red-flag warning: If you or someone else is experiencing symptoms that may suggest type 1 diabetes or a hyperglycaemic emergency — such as abdominal pain, vomiting, dehydration, deep or laboured breathing, confusion, or drowsiness — seek same-day urgent medical attention. Call 999 or go to your nearest A&E department immediately. These symptoms may indicate diabetic ketoacidosis (DKA), which requires emergency treatment and cannot be managed through routine GP pathways.
If your result is in the non-diabetic hyperglycaemia range (42–47 mmol/mol), your GP will typically:
-
Offer lifestyle advice focused on diet, physical activity, and weight management
-
Refer you to the NHS Diabetes Prevention Programme (NHS DPP), a nationally commissioned, evidence-based behavioural intervention
-
Arrange a repeat HbA1c test at least annually to monitor for progression, or sooner (for example, within three to six months) if your result is near the diagnostic threshold or your clinical circumstances change
If your result is 48 mmol/mol or above and is confirmed on a second sample, a diagnosis of type 2 diabetes will be made. If HbA1c is unreliable or the result is discordant with symptoms, fasting plasma glucose or an OGTT may be used to confirm the diagnosis. Your GP surgery or diabetes team will then initiate a structured care plan, which typically includes diabetes education (such as the DESMOND programme), medication review, and regular monitoring of HbA1c, renal function, blood pressure, and cholesterol.
For people already on treatment, a rising HbA1c may prompt a review of current medications, adherence, dietary habits, or the presence of intercurrent illness. Contact your GP or diabetes nurse if you notice symptoms of hyperglycaemia (excessive thirst, frequent urination, fatigue) or hypoglycaemia (shakiness, sweating, confusion), or if your home glucose readings are consistently outside your agreed target range. Early review helps prevent complications and supports better long-term outcomes.
Managing HbA1c Levels: NICE-Recommended Approaches
NICE NG28 recommends lifestyle modification as the cornerstone of HbA1c management, with metformin as first-line pharmacotherapy and stepwise addition of SGLT-2 inhibitors, DPP-4 inhibitors, or other agents based on individual cardiorenal risk.
Effective management of HbA1c involves a combination of lifestyle modification and, where necessary, pharmacological treatment. NICE guideline NG28 (Type 2 Diabetes in Adults) provides a clear, stepwise framework that prioritises patient-centred care and shared decision-making.
Lifestyle interventions remain the cornerstone of management at every stage:
-
Diet: A balanced diet low in refined carbohydrates and added sugars, with an emphasis on vegetables, wholegrains, lean protein, and healthy fats. Low-calorie dietary programmes have demonstrated significant HbA1c reductions and, in some cases, remission of type 2 diabetes.
-
Physical activity: NICE recommends at least 150 minutes of moderate-intensity aerobic activity per week, alongside resistance exercise, both of which improve insulin sensitivity.
-
Weight management: Even a modest reduction of 5–10% of body weight can meaningfully lower HbA1c in people who are overweight.
Pharmacological management follows a stepwise, individualised approach in line with NICE NG28:
-
First line: Metformin remains the preferred initial agent for most adults with type 2 diabetes, due to its efficacy, safety profile, and low cost. It works by reducing hepatic glucose output and improving peripheral insulin sensitivity. If metformin is contraindicated or not tolerated, an SGLT-2 inhibitor or DPP-4 inhibitor may be considered as monotherapy.
-
Early addition of an SGLT-2 inhibitor: NICE recommends considering an SGLT-2 inhibitor alongside metformin (or as monotherapy if metformin is not tolerated) for people with established atherosclerotic cardiovascular disease, chronic kidney disease, or heart failure, irrespective of baseline HbA1c, given the evidence of cardiorenal benefit.
-
Second line (if HbA1c remains above target): Options include an SGLT-2 inhibitor, DPP-4 inhibitor, sulphonylurea, or pioglitazone, chosen according to individual cardiovascular and renal risk profiles, weight, and patient preference.
-
GLP-1 receptor agonists are generally considered after failure of other oral agents and are subject to specific NICE criteria, including BMI thresholds and, in some cases, established cardiovascular indications. Availability may depend on relevant NICE Technology Appraisals.
-
Insulin therapy is considered when oral and injectable non-insulin agents are insufficient to achieve glycaemic targets.
Regular HbA1c monitoring — typically every three to six months when treatment is being adjusted, and every six to twelve months once stable — allows timely treatment escalation and helps prevent the long-term complications of poorly controlled diabetes, including retinopathy, nephropathy, and cardiovascular disease.
If you experience any suspected side effects from your diabetes medicines, you can report these to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. Your GP or pharmacist can also advise you on this process.
Frequently Asked Questions
How do you convert HbA1c from mmol/mol to a percentage?
Use the standard formula: NGSP (%) = (0.09148 × IFCC mmol/mol) + 2.152. For example, 48 mmol/mol equals approximately 6.5% and 53 mmol/mol equals approximately 7.0%.
What HbA1c level is diagnostic of type 2 diabetes in the UK?
An HbA1c of 48 mmol/mol or above is diagnostic of type 2 diabetes in the UK, provided it is confirmed on a second venous blood sample in an accredited laboratory, unless symptoms of diabetes are already present.
Can certain medical conditions make HbA1c results inaccurate?
Yes — conditions such as haemolytic anaemia, iron deficiency anaemia, haemoglobin variants, recent blood transfusion, and advanced chronic kidney disease can falsely lower or raise HbA1c, so alternative tests such as fasting plasma glucose or fructosamine may be recommended.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
